Rickettsialpox in a New York City hospital, 1980 to 1989.
BACKGROUND
Rickettsialpox is caused by Rickettsia akari, which is transmitted from rodents to humans by bloodsucking mites. The initial skin lesion forms an eschar and is followed by the development of fever, malaise, myalgia, and 5 to 40 maculopapules and papulovesicles. The disease, which responds to tetracycline, can be mistaken for chickenpox. The diagnosis has been based on an increase in serum antibody titers against R. akari over a period of three to eight weeks. We discuss a more rapid technique that uses direct immunofluorescence to identify R. akari in paraffin-embedded tissue, and we describe the histopathological findings of lesional skin.


METHODS
We studied 13 patients (age, 11 months to 58 years) who were seen at Lincoln Hospital in New York City from 1980 to 1989 and were suspected of having rickettsialpox. In nine patients serum samples were obtained during the acute and convalescent phases of the illness for indirect fluorescent-antibody testing. Punch-biopsy specimens of skin lesions were examined by microscopy and by direct fluorescent-antibody testing with an anti-R. rickettsii globulin conjugated with fluorescein isothiocyanate.


RESULTS
The diagnosis was confirmed in all 13 patients by indirect or direct fluorescent-antibody techniques. Direct fluorescent-antibody testing of eschars from seven patients was positive in five patients, but negative in two patients who had serologically confirmed rickettsialpox. In contrast, direct fluorescent-antibody testing of papulovesicles from nine patients was positive in only one patient. Histopathological analysis of the eschars revealed extensive necrosis and inflammation. In biopsy specimens of papulovesicles, dermal edema, subepidermal vesicles, and vascular changes were present.


CONCLUSIONS
The combination of direct fluorescent-antibody testing of an eschar from the presumed site of inoculation and histopathological examination of papulovesicles for distinctive features represents an improved method of diagnosing rickettsialpox.
Kass
E M
EM
Department of Dermatology, New York Medical College, NY.
Szaniawski
W K
WK
Levy
H
H
Leach
J
J
Srinivasan
K
K
Rives
C
C
D000328:Adult; D000907:Antibodies, Bacterial / Q000032:analysis; D001907:Boutonneuse Fever / Q000175:diagnosis; D002648:Child; D005260:Female; D005455:Fluorescent Antibody Technique; D006786:Hospitals, Urban; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D009519:New York City; D012281:Rickettsia / Q000276:immunology / Q000302:isolation & purification; D012282:Rickettsia Infections / Q000175:diagnosis* / Q000473:pathology; D012284:Rickettsia rickettsii / Q000302:isolation & purification; D012373:Rocky Mountain Spotted Fever / Q000175:diagnosis; D012867:Skin / Q000382:microbiology / Q000473:pathology; D017192:Skin Diseases, Bacterial / Q000175:diagnosis* / Q000382:microbiology / Q000473:pathology
D000907:Antibodies, Bacterial